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ABSTRACT
Assessing similarity is highly important for bioin-
formatics algorithms to determine correlations be-
tween biological information. A common problem is
that similarity can appear by chance, particularly for
low expressed entities. This is especially relevant in
single-cell RNA-seq (scRNA-seq) data because read
counts are much lower compared to bulk RNA-seq.
Recently, a Bayesian correlation scheme that assigns
low similarity to genes that have low confidence ex-
pression estimates has been proposed to assess
similarity for bulk RNA-seq. Our goal is to extend the
properties of the Bayesian correlation in scRNA-seq
data by considering three ways to compute similarity.
First, we compute the similarity of pairs of genes over
all cells. Second, we identify specific cell populations
and compute the correlation in those populations.
Third, we compute the similarity of pairs of genes
over all clusters, by considering the total mRNA ex-
pression. We demonstrate that Bayesian correlations
are more reproducible than Pearson correlations.
Compared to Pearson correlations, Bayesian corre-
lations have a smaller dependence on the number of
input cells. We show that the Bayesian correlation al-
gorithm assigns high similarity values to genes with
a biological relevance in a specific population. We
conclude that Bayesian correlation is a robust simi-
larity measure in scRNA-seq data.
INTRODUCTION
Single-cell RNA-seq (scRNA-seq) is one of the most recent
advances in single-cell technologies and it has been widely
used to study multiple biological processes (1–9). Standard
bulk RNA sequencing retrieves the average of RNA ex-
pression from all cells in a specific sample, thus provid-
ing an overall picture of the transcriptional activity at a
given time point from a mixed population of cells. How-
ever, within the study of heterogeneous populations it is
not possible to understand the contribution of individual
cell types, which is needed to dissect precise mechanisms.
scRNA-seq overcomes the limitations of bulk RNA-seq by
sequencing mRNA in each cell individually, making it pos-
sible to study cells at a genome-wide transcriptional level
within heterogeneous samples. However, due to the small
amount of mRNA sequenced within a cell, typically 80–
85% of all genes remain undetected, a phenomenon known
as dropout. This results in an incomplete picture of the
mRNA expression pattern within a cell.
A similarity measure in mathematics is a function, with
real values, that quantifies how similar two objects are. Sev-
eral techniques use different notions of similarity to visual-
ize data such as PCA or t-SNE. Some techniques use sim-
ilarity to cluster cells in scRNA-seq, such as Seurat (10),
SCENIC (11) or Cell Ranger (12).
The similarity measure is important because it deter-
mines the clustering. Kim et al. (13) benchmarked the Pear-
son distance and Euclidean distance methods to cluster cells
and found that correlation metrics perform better than the
Euclidean distance metrics. Recently, Skinnider et al. (14)
evaluated the multiple existing methods to assess gene-to-
gene similarity and cell-to-cell similarity and their perfor-
mance to cluster cells, reconstruct cell networks or link gene
expression to diseases in different conditions. A review of
the clustering methods has been done by Qi et al. (15).
Assessing similarity between genes is challenging since
measurements of small populations with large uncertainties
may lead to false correlations. If a gene’s expression is so
low that it only registers zero or a few reads per cell, then
its expression pattern across cells cannot be meaningfully
related to that of other genes; there is simply too much un-
certainty about the real expression levels of that gene. In a
*To whom correspondence should be addressed. Tel: +41 613328741; Email: daniel.sanchez@dbmr.unibe.ch
†The authors wish it to be known that, in their opinion, the last two authors should be regarded as joint last authors.
C© The Author(s) 2020. Published by Oxford University Press on behalf of NAR Genomics and Bioinformatics.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work
is properly cited. For commercial re-use, please contact journals.permissions@oup.com
D
ow
nloaded from
 https://academ
ic.oup.com
/nargab/article/2/1/lqaa002/5715215 by U
niversitaetsbibliothek Bern user on 13 August 2020
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
5
9
1
8
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
2 NAR Genomics and Bioinformatics, 2020, Vol. 2, No. 1
typical scRNA-seq dataset, the majority of genes may be
in this situation, so that gene–gene correlation analysis is
swamped with meaningless or spurious correlations.
In the context of this project, we aim to determine simi-
larity of genes in two distinct conditions. Assessing similar-
ity between genes has previously been used in biology for
biomarker discovery in cancer (16,17), to find patterns in
gene expression (18) or to build gene expression networks
(19,20). There are methods that use the notion of similar-
ity to infer the gene regulatory dynamics. Some examples
are SCENIC (11) or NetworkInference (21). These tech-
niques rely on data transformations and corrections of the
dropout, but do not incorporate a notion of uncertainties
in the measurements.
Noise in gene expression measurements has been mod-
eled and studied to identify differentially expressed genes
(22–24). Recently, uncertainties have been incorporated in
methods to study differential expression in RNA-seq exper-
iments (25). Noise is especially important in scRNA-seq be-
cause of the low number of read counts. Therefore, methods
to assess similarity in bulk RNA-seq may not be appropriate
for scRNA-seq. Thus, methods need to be modified prop-
erly in order to maintain reproducibility. A simple solution
is the removal of cells with a low number of read counts and
low expressed genes, which is the currently used method of
single-cell analysis (26). However, there is not a systematic
method to select a threshold and it highly depends on the
population being studied.
In order to address limitations dependent on the noise,
Bayesian statistics have been used to study biological
processes (27,28). Bayesian statistics have been used for
high-throughput sequencing (HTS) experiments, Hardcas-
tle and Kelly (29) developed methods to assess differen-
tial expression in paired samples and proved that their
Bayesian method outperforms generalized linear models.
For scRNA-seq data, Sekula et al. (30) proposed a Bayesian
scheme to identify differentially expressed genes. Recently,
we have proposed a Bayesian correlation scheme to asses
similarity between two entities in HTS experiments (31,32).
Such Bayesian correlation considers uncertainties in the
measurements, and therefore, assign low values to correla-
tions coming from low expressed genes using a prior be-
lief and compute posterior belief based on data observa-
tion. In our previous work, we have shown the properties
of the different possible priors and we have proved that
the Bayesian correlation computation is a kernel. However,
there are several considerations that need to be addressed
to adapt the method for scRNA-seq data. Thus, we set out
to develop new Bayesian methods to create better clustering
algorithms than the ones currently available.
One of the main considerations that needs to be ad-
dressed to deal with similarity between genes in scRNA-
seq comes from the bias in the observations because of false
zero counts, which occur in most genes because of the low
amount of mRNA sequenced in each cell. Our methodol-
ogy could be applied directly to the unique molecular iden-
tifier (UMI) matrix. However, there are several methods to
correct for the dropout by imputing gene expression based
on the gene expression of other cells. For example, MAGIC
corrects gene expression with the gene expression of other
cells modeled as a diffusion map (33). scImpute corrects
the dropout using similar cells and genes not affected by
dropout (34). SAVER uses a negative binomial to model
gene expression in each cell and corrects dropout using the
expression of other genes as predictors in a LASSO regres-
sion (35,36). All these methods follow the same principle
by sacrificing part of the single-cell structure of the data in
order to obtain a better resolution of the different popula-
tions. It is unclear how these corrections affect the similarity
between genes and it needs to be addressed.
An additional consideration that needs to be addressed
in scRNA-seq experiments is the number of sequenced cells.
Simulation methods for scRNA-seq data are not a mature
field and could not reproduce all the biological mechanisms
present in an experiment. To study the effect of the number
of cells on the reproducibility of the results, we sequenced
parenchymal and non-parenchymal cells from a mouse liver.
To test the sensitivity of the methods, four samples with an
increasing number of input cells were explored (1000, 2000,
5000 and 10 000 cells). To avoid biological noise, samples
sequenced were from the same animal. Thereafter, in order
to study the effect of biological noise, we compare the hepa-
tocytes from our samples with hepatocytes from the mouse
cell atlas (MCA) (37).
In this manuscript, we show that Bayesian correlation
is a robust similarity measure for pairs of genes in single-
cell RNA-seq. We show that the reproducibility of Bayesian
correlation is higher than the reproducibility of Pear-
son correlation. We show that the results obtained with
Bayesian correlation have a small dependence on the num-
ber of cells, making the method suitable to study rare pop-
ulations. Finally, we show that biologically relevant genes
tend to appear more often in the top correlated pairs using
Bayesian correlations.
MATERIALS AND METHODS
Mathematical formulation of the Bayesian correlation
method
After counting the aligned reads to exons and debarcoding
the reads from cells, the output of an scRNA-seq experi-
ment is the n × m UMI matrix, R, where n is the number of
genes and m is the number of cells. Ideally, we would cor-
relate the true fraction of UMIs, pie, of gene i in cell e. A
trivial approximation is to normalize the data dividing ev-
ery UMI by the total number of UMIs in that cell, that is
pie ≈ Rie/Re. Bayesian schemes try to approximate pie us-
ing a prior belief and compute posterior belief based on data
observation.
Assume we have Rie UMIs of gene i in cell e and the total
UMIs in that cell are Re. The empirical estimate is pie =
Rie/Re. Then, Pearson correlation can be computed as
ri j = Cove(pie, p je)√
Vare(pie)Vare(p je)
, (1)
while the Bayesian scheme would give us
pie ∼ Beta(α0ie + Rie, β0ie + Re − Rie), (2)
where (α0ie, β
0
ie) is the prior that is updated with the exper-
imentally observed UMIs leading to the posterior. In that
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scenario, the covariance and variance are computed as
Cov(pie, p je) = E(Cov(pie, p je|e))
+Cov(E(pie|e), E(p je|e)) (3)
and
Var(pie) = E(Var(pie|e)) + Var(E(pie|e)), (4)
with
E(pie|e) = α
0
ie + Rie
α0ie + β0ie + Re
. (5)
Then, the Bayesian correlation is defined as
rbi j =
Cov(pie, p je)√
Var(pie)Var(p je)
. (6)
We computed the Pearson coefficients with the R func-
tion cor, and the Bayesian correlations were computed with
a custom R script. See the ‘Data Availability’ section.
Cell isolation
Hepatocytes were isolated by a two-step collagenase perfu-
sion. Animals were anesthetized (fentanyl 50 g/kg, mida-
zolam 5 mg/kg, medetomidine 500 g/kg, i.p.), immobi-
lized in a supine position and the liver and portal vein ex-
posed. The portal vein was cannulated with a 22G catheter
and perfusion at 4 ml/min with the buffers allowed to run
to waste through an incision in the inferior vena cava. The
liver was perfused with 10 ml of HBSS (Mg2+, Ca2+ free,10
mM HEPES, pH 7) followed by 25 ml of HBSS containing
EDTA (10 mM HEPES, pH 7, 5 mM EDTA). The EDTA
was removed from the liver by perfusion with 10 ml of HBSS
followed by digestion with 25 ml of HBSS containing col-
lagenase [10 mM HEPES, 1 mM CaCl2, 0.5 mg/ml colla-
genase IV, 0.01 mg/ml collagenase 1A (Sigma)]. The liver
was then removed and the cells released by cutting the cap-
sule and gentle agitation of the digested liver in stop buffer
(HBSS, 10 mM HEPES, pH 7, 5 mM EDTA, 10 mM cit-
rate, 1% FBS) and passed through a 70 m filter. The cell
suspension was spun at 30 × g for 5 min to pellet most of
the hepatocyte fraction, the supernatant collected and rem-
nant cells pelleted at 250 × g for 5 min. The cell pellet was
washed once in stop buffer and resuspended in 20% isotonic
Percoll and overlaid on a layer of 80% isotonic Percoll and
spun at 500 × g for 10 min. The cells at the interface of the
two Percoll layers were collected and washed in PBS, resus-
pended in PBS and counted using a cell counter (BioRad
TC 20). This resulted in a cell suspension with a diminished
number of hepatocytes but contained enough to allow the
sequencing of a representative number of cells.
Library preparation
scRNA-seq libraries were prepared from 1000, 2000, 5000
and 10 000 cells using the Chromium Single Cell 3′ Library
& Gel Bead Kit v3 (10x Genomics). Libraries were prepared
according to the manufacturer’s protocol.
Sequencing
Sequencing was performed on a NovaSeq 6000 S2 flow cell.
Read 1 consisted of 26 cycles (10x Genomics barcode plus
UMI) followed by a single Illumina i7 index read of 8 cy-
cles and read 2 of 91 cycles to determine transcript-specific
sequence information.
Read alignment
The function cellranger count from Cell Ranger was used to
transform the fastq files with the parameter expect-cells set
to 1000, 2000, 5000 or 10 000. The reference genome was the
mm10 available at Illumina Cell Ranger web page. Next, we
used cellranger mat2csv to generate the UMI matrix.
Data preprocessing
First, we created an SCE object with the function Single-
CellExperiment from the R package SingleCellExperiment.
The UMI matrix was filtered as follows: first, genes with
0 reads were excluded; second, cells with >15% of UMIs
in mitochondrial genes were removed (mitochondrial gene
list is included in the Supplementary Material). Cells with
>25% UMIs in globin genes were removed. Finally, only
genes expressing >1 UMI in at least two cells were con-
sidered. Additionally, for the 5000-sample, a cell containing
110 270 UMIs was considered an outlier and it was removed
because the second cell with most UMIs had 26 038 UMIs.
MCA data acquisition
We downloaded the Liver1 rm.batch dge.txt file con-
taining the gene expression from the MCA and the
MCA CellAssignments.csv containing cell information.
Batch=Liver 1 was included for analysis. Only genes ex-
pressing >1 UMI in at least two cells were considered. Cells
with Annotation containing the word hepatocyte were con-
sidered hepatocytes. In total, 166 hepatocytes were consid-
ered for analysis.
Dimensionality reduction and clustering
In order to cluster the data and find the different cell
populations and their markers, we followed the proce-
dure of Seurat 2 (10). The filtered UMI matrix was trans-
formed into a Seurat object with CreateSeuratObject with
parameters min.cells = 1 and min.genes = 2. We normal-
ized the data with the R function NormalizeData from
Seurat with parameters normalization.method = ‘LogNor-
malize’ and scale.factor = 10 000. Then, the data were
scaled with the Seurat function ScaleData with parame-
ter vars.to.regress = c(‘nUMI’). The different clusters were
identified using the Seurat function FindClusters with pa-
rameters reduction.type = ‘pca’, dims.use = 1:8, resolution
= 1.0, print.output = 0 and save.SNN = TRUE. t-SNE di-
mensionality reduction was done with the Seurat function
RunTSNE with parameters dims.use = 1:8 and do.fast =
TRUE. The different markers of each cluster were identified
with the function FindAllMarkers with parameters only.pos
= TRUE, min.pct = 0.25 and thresh.use = 0.25.
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Dropout correction
We corrected the dropout from the UMI matrix with the
magic function from the R package Rmagic with the pa-
rameters genes set equal to ‘all genes’ and default param-
eters. Any resulting negative expression was replaced with
0.
Notions of similarity
In this manuscript, we consider three notions of similarity
between genes: (i) All-cell correlation: The correlation of
gene i and gene j is the correlation coefficient using all cells.
(ii) Cluster correlation: The correlation of gene i and gene j
is the correlation coefficient using each cluster as condition,
where the gene expression is the sum of the gene expression
in all cells. That is, let K be the number of clusters, and let
(RC jin) be the UMIs of gene i of cell n in cluster j. We trans-
formed our K matrices in the reduced n × k dimensional
matrix (Bij) as follows:
Bi j =
K j∑
n=1
RC jin, (7)
where Kj is the number of cells in cluster K. The Bayesian
correlation algorithm is applied to the bulk-like RNA-seq
matrix (Bij). (iii) In-cluster correlation: The correlation of
gene i and gene j is the correlation coefficient using all cells
in a specific cluster.
Evaluation criteria
In order to evaluate the robustness of the method, we com-
pare the results of the method on two datasets, and we look
at the intersection of the identified pairs above a certain
threshold. Mathematically, let XA be a UMI matrix, A =
{A1, A2, . . .} be the set of the pairs sorted by correlation
and AN := {A1, . . . , AN} be the first N elements of A. We
define the agreement between two datasets, XA and XB, as
#(AN ∩ BN)/N, where # denotes the number of elements in
a set. If the two datasets are coming from different samples,
the agreement is called reproducibility. The intersection is
computed with the R function intersect applied to the gene
names of the UMI matrices.
RESULTS
Bayesian correlation and Pearson correlation agreement in-
creases with the number of cells
We studied the first notion of similarity: all-cell correlation.
To study the effect of the number of cells on the repro-
ducibility of the results, the Bayesian correlation was com-
puted and was compared with the Pearson correlation.
After the data processing, we ended up with four samples
of 705, 1213, 2939 and 5520 cells. We refer to these samples
as 1000-sample, 2000-sample, 5000-sample and 10k-sample.
Our first step was to compare our Bayesian similarity
measure, using as a prior α0ie = 1/n and β0ie = 1 − 1/n with
Pearson correlation. In doing so, we split the samples into
two groups, randomly assigning half of the cells to group
A and the other half to group B. All pairwise correla-
tions were independently computed for each group. In Fig-
ure 1A, we observed that the agreement between the two
groups is higher using the Bayesian method. As the num-
ber of input cells increases, the agreement between the two
groups increases. In Figure 1B, scatter plot of Bayesian cor-
relation and Pearson correlation for all pairs of genes is
shown. The Bayesian correlation was systematically lower.
In Figure 1C, the distributions of gene expression of the
top 3000 correlated pairs for Bayesian and Pearson correla-
tions are shown. This result shows that the Bayesian corre-
lation algorithm tends to identify correlations in genes that
are highly expressed, compared with the correlations iden-
tified by Pearson correlation that identifies correlations in
low expressed genes. We observed some low expressed genes
among the Bayesian correlations, showing that Bayesian
correlation is not equivalent to a higher threshold.
Bayesian correlation is more robust than Pearson correlation
to study similarity within small populations
We have shown a pronounced discrepancy between Pearson
and Bayesian correlations when the number of input cells is
small. This result motivated us to study correlations within
the different populations found in our data. The identifica-
tion of the different cell populations in our samples can be
found in Appendix A.
First, we restricted our analysis to the hepatocyte frac-
tion. There are 33, 58, 111 and 200 hepatocytes in the 1000-
sample, 2000-sample, 5000-sample and 10k-sample, respec-
tively. Each dataset was split into two random groups. In
Figure 2A (solid line), we observe that the agreement be-
tween the two groups using both methods, Pearson and
Bayesian, is poor (below 5%). For Pearson correlations, this
is due to the fact that the small number of cells results in
thousands of Pearson coefficients equal to 1. The Bayesian
methods gave us a slight improvement in the reproducibility,
but there are not enough data to get a marked improvement
from the posterior. However, when the dropout is corrected
(dashed lines) the reproducibility increases drastically. As
before, we observe that the agreement using Bayesian cor-
relations is higher than that using Pearson correlations. We
do not discern change for different levels of MAGIC cor-
rection.
Next, we restricted our analysis to the MAGIC corrected
data. In Figure 2B, we observed that the reproducibility
for correlations within small clusters is much higher with
the Bayesian correlation algorithm than with Pearson cor-
relation. This difference was more pronounced for a small
sample size, with around 90% of irreproducible results for
Pearson in the 1000-sample and 2000-sample scenarios. The
Bayesian correlation was systematically lower compared
with the Pearson correlation (Figure 2C). This effect de-
creased with the increase in the number of input cells. The
distribution of the expression of the genes in the top 3000
correlated pairs for Bayesian and Pearson correlations is
shown in Figure 2D. The Pearson method identified cor-
relations in low expressed genes that are not considered by
the Bayesian method.
In Supplementary Figure S1, we include all the other cell
clusters and show that the agreement with Bayesian correla-
D
ow
nloaded from
 https://academ
ic.oup.com
/nargab/article/2/1/lqaa002/5715215 by U
niversitaetsbibliothek Bern user on 13 August 2020
NAR Genomics and Bioinformatics, 2020, Vol. 2, No. 1 5
A B
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Figure 1. All-cell correlation. (A) Percentage of pairs of correlated genes found in the two random groups as a function of the number of links sorted by
correlation include repetitions (A correlated with B and B correlated with A are both included). (B) Scatter plot of the Pearson correlation (x-axis) and
Bayesian correlation (y-axis) for all genes, colored by the logarithm of the density. (C) Histogram of the total expression of the genes found in the top 3000
links.
tions is higher than the agreement with Pearson correlations
in all our populations.
Taken together, our results suggest that Bayesian corre-
lations are more robust than Pearson correlations for small
populations by lowering the similarity between pairs of low
expressed genes.
Bayesian correlation is more robust than Pearson correlation
to study cluster similarity
Single-cell sequencing allows the study of cells individually.
However, combined with clustering techniques, it is possi-
ble to obtain bulk-like RNA-seq samples from pure popu-
lations. In this section, the single cells are grouped to study
Bayesian cluster correlation.
To test the reproducibility, the UMI matrix was split into
two datasets and then the transformation of Equation (7)
was applied.
We showed that the reproducibility of our method is
higher when the Bayesian method is applied. The agreement
between Pearson correlations and Bayesian correlations in-
creased with the number of cells (Figure 3A). In Figure 3B,
scatter plots of the Bayesian correlation (y-axis) versus the
Pearson correlation (x-axis) are shown. The Bayesian corre-
lation was systematically lowered. In Figure 3C, the distri-
butions of the gene expression of the genes in the top 3000
correlated pairs for Bayesian and Pearson correlations are
shown. As in the previous sections, the genes identified only
by Pearson correlations were low expressed.
Taken together, this suggests that Bayesian correlations
are more robust than Pearson correlations for pseudo-bulk
RNA-seq samples.
Robustness of Bayesian method for a varying number of cells
Thus far, to study the reproducibility of our method, we
have compared it with the Pearson correlation by splitting
each of our datasets into two groups. To determine the im-
portance of the number of cells in an experiment, we next
studied the agreement between our different samples.
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D
Figure 2. In-cluster correlation: example of hepatocytes. (A) Percentage of pairs of correlated genes found in the two random samples as a function of
the number of links sorted by correction for different values of MAGIC correction. (B) Percentage of pairs of correlated genes found in the two random
samples as a function of the number of links sorted by correlation. (C) Scatter plot of the Pearson correlation (x-axis) and Bayesian correlation (y-axis)
for all genes, colored by the logarithm of the density. (D) Histogram of the total expression of the genes found in the top 3000 links.
In the previous sections, a strong disagreement between
Bayesian and Pearson methods was observed in the cluster
correlations and in-cluster correlations. For this reason, we
restricted our analysis to those two scenarios.
We first restricted our analysis to the cluster identified
as the hepatocyte population with the MAGIC corrected
data. Figure 4A shows an agreement between the differ-
ent samples of around 50% for the top 20 000 links with
the Bayesian method. On the contrary, Pearson correlation
showed a low agreement between samples, which was close
to 0%.
Second, we transformed our samples in bulk-like sam-
ples by means of Equation (7). In Figure 4B, we observed
that the agreement between samples is around 60% with the
Bayesian method when 1000 links are considered. For the
Pearson correlation, the agreement between the samples is
smaller and it reaches 30% when 10 000 links are consid-
ered.
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C
Figure 3. Cluster correlation. (A) Percentage of pairs of correlated genes found in the two random samples as a function of the number of links sorted by
correlation. (B) Scatter plot of the Pearson correlation (x-axis) and Bayesian correlation (y-axis) for all genes, colored by the logarithm of the density. (C)
Histogram of the total expression of the genes found in the top 3000 links.
A B C
Figure 4. Percentage of correlated pairs found in the different samples using the Bayesian (red line) and the Pearson (blue line) method as a function
of the number of links considered sorted by correlation. (A) Correlation in hepatocytes. (B) Correlation in all clusters. (C) Reproducibility between the
hepatocytes from our samples and the hepatocytes from the MCA.
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Bayesian correlations are more robust than Pearson correla-
tions to biological noise
So far, we have shown that Bayesian correlations are more
resilient to noise than Pearson correlations in our samples.
A next step is to study the effect of the biological noise. In
doing so, we compare our data with publicly available data
from the MCA.
In Supplementary Figure S2A, we show that, after split-
ting the MCA hepatocytes into two groups, the agreement
between the groups is higher with the Bayesian correlation
algorithm than with the Pearson correlation. Therefore, the
MCA hepatocytes present similar properties to ours.
In Figure 4C, we show the agreement between our hepa-
tocytes and the MCA hepatocytes. In doing so, we compare
directly their UMI matrix with ours; differences regarding
the sample preparation, their microwell sequencing or small
differences due the reference genome are not studied in de-
tail. We observe that using Bayesian correlation, the sam-
ples show a higher reproducibility than using Pearson cor-
relations.
Taken together, these results suggest that Bayesian corre-
lations are more resistant to biological noise than Pearson
correlations.
Bayesian in-cluster correlation assigns high values to cell pop-
ulation markers
We have shown that Bayesian correlation increases the re-
producibility by assigning low correlations to low expressed
genes. In this section, we demonstrate that the genes present
among the most highly correlated pairs of genes are biolog-
ically meaningful.
In order to investigate the biological meaning of the cor-
related pairs found with our Bayesian method, a set of hep-
atocyte markers from PanglaoDB (38) was downloaded on
17 April 2019. Figure 5 shows the percentage of genes in the
top correlations that are in this public database as a function
of the number of links considered for the different clusters
with in-cluster correlation. For the four samples, one cluster
contained more genes of the database among the top corre-
lated links than the others. In the four cases, that cluster was
the one identified as the hepatocyte cluster.
We have shown that the Bayesian correlation can be used
to identify cell populations by looking at the genes present
in the top correlated pairs. To investigate further the per-
formance of this identification method, we compared it
with two analogous methods. The first method is the same
method using Pearson correlation. The second method is to
intersect the markers obtained with Seurat with the hepato-
cyte marker list.
In order to make a fair comparison, when N genes are
considered with the latter identification method, we choose
the number of links that result in N unique genes. Figure 6A
shows that for a small number of genes the Bayesian correla-
tion algorithm selected more hepatocyte markers than Seu-
rat or Pearson correlation. For a larger number of cells (Fig-
ure 6B–D), the Bayesian correlation and Seurat showed a
similar performance and both are higher than Pearson cor-
relation. When a large number of genes (e.g. 100 genes) are
considered, the three methods show a similar performance.
These results suggest that Bayesian correlation assigns
higher similarity values to pairs of genes that are biologi-
cally relevant.
DISCUSSION
We have presented a similarity measure of genes in scRNA-
seq data, which suppresses correlations from low expressed
genes, by extending the notion of Bayesian similarity (31)
from RNA-seq to scRNA-seq data. Our new Bayesian
method allows scientists to study similarity between pairs of
genes without discarding low expressed entities and avoid-
ing biases. Thus, this new methodology is more resilient to
noise and gives more reproducible results compared to the
Pearson method. Moreover, the Bayesian scheme assigns
high correlation to biologically relevant genes.
After splitting our samples into two groups, we observed
that the Bayesian correlation is more reproducible than
the Pearson correlation because it is not biased by low ex-
pressed genes. There was a more pronounced effect when
the number of input cells was small. This result suggests that
the Bayesian method can be useful to study very heteroge-
neous and rare populations.
We have observed that the dropout correction increases
the reproducibility. Restricting the same methodology to
our different clusters, after correcting the dropout we ob-
served that the agreement of the Bayesian correlations was
higher than Pearson correlation. As before, we have seen
that this difference in the methods decreases as the number
of input cells increases.
Since the all-cell correlation is biased by the number of
cells in a cluster, we decided to study the cluster correlation
by summing the gene expression of all cells for each gene.
Clusters with low cell numbers have low total reads and
therefore are less resilient to noise. Note that the Bayesian
correlation accounts for the total number of reads when
computing the correlation. Applying the same methodol-
ogy to the clusters, we observed that Bayesian correlations
were more reproducible and are not biased by low expressed
genes compared to Pearson correlations.
After studying the three notions of correlation in our dif-
ferent samples, we have compared the results of the different
samples, by comparing 1000 to 2000, 2000 to 5000 and 5000
to 10k. We studied the correlation in hepatocytes and found
that the agreement between samples was around 50% for
the Bayesian method and close to 0 for the Pearson correla-
tions. Then, we studied the cluster correlation and showed
that the samples agree more with the Bayesian correlation
than with the Pearson correlation.
Low expressed genes were detected in the top correlated
genes using Bayesian correlations; therefore, the method is
not equivalent to a threshold.
In order to understand the biological noise, we have
downloaded hepatocyte data from the MCA. Comparing
their data with ours, we have observed that the reproducibil-
ity is higher when Bayesian correlations are considered.
In all the considered scenarios, we have observed that
the agreement between the groups and samples was larger
when using Bayesian correlations. Moreover, we observed
that this effect appears by systematically lowering the cor-
relations coming from low expressed genes. Therefore, we
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Figure 5. (A) 1000-sample, (B) 2000-sample, (C) 5000-sample and (D) 10k-sample. Percentage of genes in the top correlated pairs that are in the hepatocyte
marker list from PanglaoDB as a function of the number of links considered sorted by Bayesian correlation. The correlation is computed as in a cluster
correlation for each cluster independently identified with Seurat.
conclude that Bayesian correlations are more robust than
Pearson correlations.
To study the biological relevance of the correlated pairs
identified by Bayesian correlation, we compared them with
genes specific for hepatocytes from PanglaoDB. We have
shown that the genes among the top correlated pairs tend
to include more markers than Pearson correlation. Inter-
estingly, when the number of cells is small, the performance
of the method to identify markers is higher than the per-
formance of Seurat (10). There are two things that explain
this fact. First, Bayesian correlation assigns higher values to
high expressed genes; since markers are highly expressed,
they appear more. Second, genes with a specific function-
ality tend to be correlated with other genes important for
that function since the pathways that activate them act on
the entire population. Moreover, there are different types
of hepatocytes (e.g. periportal and pericentral) and in those
the expression of the markers is correlated.
The ability of the method to identify markers and the in-
creased reproducibility between the different experiments
suggested that the method could be adapted for cell type
identification. The optimal way to modify the Bayesian
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Figure 6. (A) 1000-sample, (B) 2000-sample, (C) 5000-sample and (D) 10k-sample. Percentage of genes in the top correlated pairs in the hepatocyte marker
list from PanglaoDB as a function of the number of genes considered in the top pairs sorted by correlation (red and green) and by P-value in the markers
identified by Seurat (blue).
correlation algorithm for cell population identification, as
well as a performance comparison with other identification
methods such as SingleR (39), is left for future work.
We will further extend the Bayesian notion of similar-
ity to mass cytometry (40) and CITE-seq (41). By combin-
ing transcriptomic and proteomic analytical tools, we will
build clustering methods to merge and validate results from
single-cell omic datasets. Development of a pipeline that in-
tegrates transcriptomic and proteomic data will clearly al-
low synergistic effects that cannot be identified by studying
data independently.
Although our work mainly addresses bioinformatics
questions, the dataset we have generated can be very useful
for experiment design for liver researchers. First, we provide
a dataset of healthy mouse liver sequenced with high cover-
age. Second, our results show which cell populations can be
identified within an scRNA-seq experiment and how many
input cells need to be used.
CONCLUSION
Taken together, our results show that results from Bayesian
correlations are more reproducible than results from Pear-
son correlations and have a higher biological relevance for
analysis of scRNA-seq. Moreover, the number of sequenced
cells has a small influence in Bayesian correlation results
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compared with Pearson correlation. Therefore, Bayesian
correlation is a more robust measure of similarity for pairs
of genes in scRNA-seq.
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APPENDIX A: CELL TYPE IDENTIFICATION
During the preparation of this bioinformatics manuscript,
we created a dataset that can be useful for liver researchers.
Our main goal is far from unraveling liver dynamics; how-
ever, we consider helpful for liver researchers to have an
analysis of the biological samples. In this appendix, we de-
scribe the populations identified by Seurat clustering as well
as the markers, and their statistical significance, we use to
classify them.
scRNA-seq samples allow the identification of multiple
parenchymal and non-parenchymal cell populations
We have identified 10, 10, 14 and 18 different cell pop-
ulations in our 1000-sample, 2000-sample, 5000-sample
and 10k-sample, respectively. The multiple populations are
shown in Figure A1.
Cell types identified and markers
1000-sample. Unsupervised clustering of the 1000-cell
sample identified 10 transcriptionally distinct populations.
The different cell populations were identified using previ-
ously published markers from the literature.
• Cluster 0: Endothelial cells
Markers: Pecam1, Ushbp1, Oit3, F8, Bmp2, C1qtnf1,
Mmrn2, Pcdh12, Dpp4, Tek, S100a1, Tie1, Egfl7, Scarf1,
Stab2, Lyve1, Icam2, Sox18, Flt4 and Nr2f2 (42–54).
• Cluster 1: Macrophages
Markers: Adgre1, Csf1r, Cd163, Cd68, Marco, Vsig4,
Irf7 and Clec4f (43,55–59).
• Cluster 2: Stellate cells
Markers: Reln, Sparc, Col1a2, Rbp1, Des, Bmp5 and
Lrat (48,59–65).
• Cluster 3: Cholangiocytes
Markers: Krt7 , Krt19, Epcam, Sox9 and St14 (59,66).
• Cluster 4: NK/T cells
T-cell markers: Cd3g, Cd247, Gata3, CD28, Lat, Cst7,
Cd3e and Cd4. NK cell markers: Nkg7, XcL1, CCl5, Cd7
and Gzmb (59,67,68).
• Cluster 5: Endothelial cells
Markers: Egfl7. Bmp2 and Clec4g (43,47,69).
• Cluster 6: Dendritic cells
Markers: Itgax Xcr1, Flt3, Cd24a, Ccr2 and Clec9a
(56,67,70–72).
• Cluster 7: Endothelial cells
Markers: Pecam1, Ushbp1, Mmrn2, Tek, Flt4 and Nr2f2
(43–46,48,53,54).
• Cluster 8: Hepatocytes
Markers: Alb, Ass1, Cyp2f2, Asgr1, Apoa1, Mup3, Pck1
and G6pc (43,59).
• Cluster 9: Immune cells of lymphoid branch
Markers: Siglech, Ly6d and Runx2 (73–76).
2000-sample. Unsupervised clustering of the 2000-cell
sample identified 10 transcriptionally distinct populations.
The different cell populations were identified using previ-
ously published markers from the literature.
• Cluster 0: Endothelial cells
Markers: Pecam1, Ushbp1, Oit3, F8, Bmp2, Mmrn2,
Pcdh12, Dpp4, Tek, S100a1, Scarf1, Stab2, Lyve1,
Icam2, Sox18, Egfl7, Flt4, Nr2f2 and Tie1 (42–54).
• Cluster 1: Macrophages
Markers: Adgre1, Csf1r, Cd163, Vsig4, Marco, Cd68,
Cd5l, Irf7 and Clec4f (43,55–59).
• Cluster 2: Endothelial cells
Markers: Clec4g, Egfl7, Bmp2, Oit3 and Mmrn2
(43,47,69).
• Cluster 3: NK/T cells
T-cell markers: Cd3g, Cd247, CD28, Lat, Cst7 and Cd3e.
NK cell markers: Nkg7, Xcl1, CCl5, Cd7 and Gzmb
(59,67,68).
• Cluster 4: Stellate cells
Markers: Hhip, Reln, Sparc, Col1a2, Rbp1, Des and Lrat
(48,59–64,77).
• Cluster 5: Cholangiocytes
Markers: Krt7, Krt19, Sox9, Epcam and Muc1
(59,66,78).
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Figure A1. t-SNE visualization of our data; cells are colored by the cluster they belong to. (A) 1000-sample; (B) 2000-sample; (C) 5000-sample; (D) 10k-
sample.
• Cluster 6: Dendritic cells
Markers: Xcr1, Flt3, Cd24a, Ccr2, Clec9a and Itgax
(56,67,70–72).
• Cluster 7: Hepatocytes
Markers: Alb, Hnf4a, Ass1, Cyp2f2, Cyp2e1, Asgr1,
Apoa1, Mup3, Pck1 and G6pc (43,59).
• Cluster 8: Endothelial cells
Markers: Pcdh12, Sox18 and Nr2f2 (43,52,54).
• Cluster 9: Immune cells of the lymphoid branch
Markers: Ly6d, Sell, Cd19, Ms4a1, Ltb and Cd37
(59,67,76,79).
5000-sample. Unsupervised clustering of the 5000-cell
sample identified 14 transcriptionally distinct populations.
The different cell populations were identified using previ-
ously published markers from the literature.
• Cluster 0: Endothelial cells
Markers: Pecam1, Ushbp1, Oit3, F8, Bmp2, Pcdh12,
Dpp4, Tek, S100a1, Scarf1, Stab2, Lyve1, Icam2, Sox18,
Egfl7, Flt4, Nr2f2 and Tie1 (42–54).
• Cluster 1: Endothelial cells
Markers: Pecam1, Ushbp1, Oit3, F8, Bmp2, Mmrn2,
Pcdh12, Dpp4, Tek, S100a1, Stab2, Lyve1, Icam2, Sox18,
Egfl7, Flt4, Nr2f2 and Tie1 (42–54).
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• Cluster 2: Macrophages
Markers: Adgre1, Csf1r, Cd163, Vsig4, Marco, Cd68,
Cd5l, Irf7 and Clec4f (43,55–59).
• Cluster 3: Endothelial cells
Markers: Pecam1, Oit3, F8, Bmp2, Mmrn2, S100a1,
Icam2, Egfl7 and Clec4g (42–45,47,48,50–54,69).
• Cluster 4: T and NK cells
T-cell markers: Cd3g, Cd247, Trac, CD28, Lat, Cst7 and
Cd3e. NK cell markers: Nkg7, Xcl1, CCl5, Cd7 and
Gzmb (59,67,68).
• Cluster 5: Macrophages
Markers: Clec4f, Csf1r, Cd163, Vsig4, Marco, Cd68 and
Cd5l (43,56–59).
• Cluster 6: Stellate cells
Markers: Hhip, Reln, Sparc, Col1a2, Rbp1, Des and Lrat
(48,59–63,65,77).
• Cluster 7: Cholangiocytes
Markers: Krt7, Krt19, Sox9, Epcam, Muc1 and St14
(59,66,78).
• Cluster 8: Dendritic cells
Markers: Xcr1, Flt3, Cd24a, Ccr2 and Clec9a
(56,67,71,72).
• Cluster 9: Hepatocytes
Markers: Alb, Ass1, Cyp2f2, Cyp2e1, Asgr1, Apoa1,
Mup3, Pck1 and G6pc (43,59).
• Cluster 10: Endothelial cells
Markers: Pecam1, Oit3, F8, Bmp2, Mmrn2, Dpp4, Tek,
S100a1, Stab2, Sox18, Egfl7, Flt4, Nr2f2 and Tie1 (42–
48,50,52–54).
• Cluster 11: B cells
Markers: Cd19, Ms4a1, Ltb, Cd37, Cd22, Cd79a, Cd79b
and Cd69 (59,67,79,80).
• Cluster 12: Immune cells of the lymphoid branch
Markers: Siglech, Ly6d, Runx2 and Klra17 (73–76).
• Cluster 13: Unknown
10k-sample. Unsupervised clustering of the 10k-cell sam-
ple identified 17 transcriptionally distinct populations. The
different cell populations were identified using previously
published markers from the literature.
• Cluster 0: Endothelial cells
Markers: Clec4g, Pecam1 and Tek (42,44,69).
• Cluster 1: Endothelial cells
Markers: Clec4g, Pecam1, Dpp4 and Lyve1
(42,43,49,69).
• Cluster 2: Macrophages
Markers: Csf1r, Adgre1, Cd163, Vsig4, Marco, Cd68,
Cd5l, Irf7 and Clec4f (55–59).
• Cluster 3: Macrophages
Markers: Adgre1, Csf1r, Cd163, Vsig4, Marco, Cd68,
Cd5l, Irf7 and Clec4f (55–59).
• Cluster 4: Endothelial cells
Markers: Oit3, Bmp2, Mmrn2, Icam2, Sox18, Flt4,
Clec4g and Egfl7 (43,45–48,50–54,69).
• Cluster 5: NK cells/T cells
T-cell markers: Trac, Cd3g and Cd2. NK cell markers:
Nkg7, Xcl1 and CCl5 (59,67,68).
• Cluster 6: Endothelial cells
Markers: Pecam1, Ushbp1, Bmp2, Stab2, Egfl7 and
Clec4g (42,43,45–48,50–54,69).
• Cluster 7: Stellate cells
Markers: Hhip, Reln, Sparc, Rbp1, Des, BMp5, Pdgfrb,
Lrat and Hand2 (48,59–65,77,81–83).
• Cluster 8: Cholangiocytes
Markers: Krt7, Krt19, Sox9, Epcam, Muc1 and St14
(59,66,78).
• Cluster 9: Hepatocytes
Markers: Alb, Apoa1, Mup3, Ass1, Cyp2f2, Cyp2e1,
Asgr1, Pck1 and G6pc (43,59).
• Cluster 10: Dendritic cells
Markers: Xcr1, Ccr2, Itgax, Flt3, Cd24a and Ccr2
(56,67,70–72).
• Cluster 11: Immune cells: B cells
Markers: Cd19, Ms4a1 and Ltb (59,67,79).
• Cluster 12: Stellate cells
Markers: Hand2, Hhip, Sparc1, Des, Reln and Rbp1
(48,59–63,77).
• Cluster 13: Unknown
• Cluster 14: Immune cells from the lymphoid branch
Markers: Siglech, Runx2 and Klra17 (73–76).
• Cluster 15: Stellate cells
Markers: Pdgfrb, Lrat, Hand2, Hhip, Reln, Sparc, Des
and Rbp1 (48,59–63,77,81).
• Cluster 16: Unknown
• Cluster 17: Endothelial cells
Markers: Ptprb and Pecam1 (42,84).
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